CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Similar documents
CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

Amber Enterprises India Ltd

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Hindustan Media Ventures

Mahindra & Mahindra Ltd.

Mahindra & Mahindra Ltd.

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Procter & Gamble Hygiene & Health Care

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Quick take. Ashok Leyland Ltd BUY. Scrappage policy to drive faster growth. Target Price. Investment Period 12 Months. 3-year price chart

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Quick take. VIP Industries BUY. Travelling smart on the luggage track. CMP Target Price `153 ` year daily price chart

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Mahindra & Mahindra Ltd.

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Matrimony.com Ltd BUY. A complete package from matchmaking to wedding. Target Price. Initiating Coverage Internet Software & Services

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

Century Plyboards Ltd

MISHRA DHATU NIGAM Ltd.

Apollo Micro Systems Ltd

TV Today Network BUY. Go with the market leader. CMP Target Price `297 `363. Initiating Coverage Media. 3-year price chart

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

Newgen Software Technologies Ltd

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Future Supply Chain Solutions Ltd

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

Varroc Engineering Ltd.

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

Transport Corporation of India

Avenue Supermarts Limited

Aster DM Healthcare Ltd

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `7,622 Target Price `8,501. 1QFY2018 Result Update Automobile

Safari Industries BUY. On a fast paced Safari. Initiating Coverage Luggage February 21, CMP Target Price `532 ` year daily price chart

Tata Consultancy Services (TCS)

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

Sandhar Technologies Limited

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

Lupin BUY. Performance Highlights. CMP `1,493 Target Price `1,809. 2QFY2017 Result Update Pharmaceutical. 3-year price chart

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `5,715 Target Price `6,006. 2QFY2017 Result Update Automobile. 3-year price chart

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

NEUTRAL. Neogen Chemicals Ltd. Issue Open: April 24, 2019 Issue Close: April 26, IPO Note Specialty Chemicals

Dr. Reddy s Laboratories

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

Lupin 1QFY2018 Result Update

Bharat Dynamics Ltd SUBSCRIBE. Issue Open: Mar 13, 2018 Issue Close: Mar 15, IPO Note Defence. Key Financials

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `440 Target Price. 3QFY2017 Result Update Pharmaceutical. Investment Period -

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

Mahindra & Mahindra BUY. CMP Target Price `860 `990. Company Update Automobile

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Quick take. Aditya Birla Nuvo BUY. Deep Value. Valuation Methodology. Exhibit 1: ABNL s Business Structure

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `390 Target Price - 2QFY2017 Result Update Pharmaceutical. Investment Period -

Aurobindo Pharma ACCUMULATE. Performance Highlights. `780 Target Price CMP `855. 2QFY2019 Result Update Pharmaceutical. Investment Period 12 months

Quick take. LT Foods BUY. A Royal Daawat for investors. Target Price. 3 year daily price chart

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `5,797 Target Price `6,560. 3QFY2017 Result Update Automobile. 3-year price chart

Century Plyboards India

FY2017 FY2018E FY2019E

Navkar Corporation BUY. Performance Update. CMP Target Price `175 `265. 2QFY2017 Result Update Logistics. Historical share price chart.

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Cipla REDUCE. Performance Highlights. CMP Target Price `564 `490. 2QFY2017 Result Update Pharmaceutical. Investment Period - 3-Year Daily Price Chart

Transcription:

5-Jan 5-Apr 5-Jul 5-Oct 5-Jan 5-Apr 5-Jul 5-Oct 5-Jan 5-Apr 5-Jul 5-Oct CCL Products Brewing Steadily CCL Products Limited (CCL) is the largest Indian manufacturer and exporter of instant coffee. With a total capacity of 35,000 TPA (tonne per annum), the company has a global market share of ~6.5%. It also has a leading market share of 24% in Indian instant coffee exports CCL exports (contributing over 90% to revenue) to over 90 countries, which have helped in registering 14% CAGR in revenue and 30% CAGR in PAT over FY2012-17. Hedged business model has created healthy moat: CCL works on cost plus margin method and places orders for green coffee only after receiving orders for instant coffee. This saves company from adverse volatility in coffee prices and has helped in maintaining operating margins at 20%+ level. Further, CCL s Vietnam expansion is an excellent strategic move, as it is preferred by importing countries due to proximity to raw material and a favorable duty structure. Ramping up of facilities to foray in newer markets: In the last two decades, CCL has expanded its capacity by over 10 times. CCL currently has 20,000 TPA of capacity in India, which is running at high utilization level of 90%+. The company is expanding its Indian capacities by 5,000 TPA to capture the new clients (especially in Japan and Europe) in the premium freeze dried coffee space with an investment of US$50mn. Vietnam plant, with a capacity of 15,000 TPA could be further expanded to export to countries like China, USA. Strong balance sheet and healthy return ratios: Its robust business model keeps on generating free cash flow in excess of `80cr every year, which would largely fund its capex requirements. Despite its intensive capex ramp up, DE ratio has come down to 0.2x in FY2017 and return ratios have been at 20%+ level. Outlook & Valuation: CCL is likely to maintain the 17%+ growth trajectory over FY18-20 backed by capacity expansion and new geographical foray. In H1FY18, the company faced some margin pressure while acquiring new clients, which we have factored in our model. However, according to us, the margin pressures would ease from FY19 onwards, once the relationship is established. The stock is currently trading at 21x FY19 EPS, which offers good opportunity to enter the stock. We initiate coverage on CCL with a Buy recommendation and Target Price of `360 (25x FY19E EPS), indicating an upside of ~20% from the current levels. Key Financials (Consolidated) Y/E March (` cr) FY2016 FY2017 FY2018E FY2019E FY2020E Net Sales 932 976 1165 1398 1595 % chg 5.9% 4.8% 19.3% 20.0% 14.1% Net Profit 122 134 139 191 228 % chg 30.0% 10.0% 3.3% 37.7% 19.2% OPM (%) 23.0% 23.9% 21.0% 22.5% 23.0% EPS (Rs) 9.2 10.1 10.4 14.4 17.1 P/E (x) 32.7 29.7 28.8 20.9 17.5 P/BV (x) 7.8 6.3 5.5 4.6 3.8 RoE (%) 24% 21% 19% 22% 22% RoCE (%) 28% 28% 25% 29% 30% EV/Sales (x) 4.5 4.2 3.5 2.9 2.5 EV/EBITDA (x) 19.5 17.6 16.7 12.9 10.9 Source: Source :Company, Angel Research; Note: CMP as of January 04, 2018 BUY CMP Target Price Investment Period Stock Info `300 `360 12 Months Please refer to important disclosures at the end of this report 1 Sector Beta 0.5 52 Week High / Low 371/250 Avg. Daily Volume 1,413 Face Value (`) 2 BSE Sensex 33,969 Nifty 10,504 Reuters Code Bloomberg Code Shareholding Pattern (%) Coffee Market Cap (` cr) 3,992 CCLP.BO CCLP.IN Promoters 45.0 MF / Banks / Indian Fls 4.1 FII / NRIs / OCBs 24.5 Indian Public / Others 26.3 Abs.(%) 3m 1yr 3yr Sensex 7.1 27.3 21.5 CCL Products (2.4) 16.1 71.3 3-year price chart 400 350 300 250 200 150 100 50 0 Source: Company, Angel Research Amarjeet S Maurya Initiating Coverage Coffee 022 3935 7800 Ext: 6831 amarjeet.maurya@angelbroking.com January 4, 2018

Company Background CCL was founded in 1994 as an Export Oriented Unit (EOU) with the right to import green coffee from any part of the world and export processed coffee across the globe, devoid of any duties. Its instant coffee manufacturing plant is located at Guntur District, Andhra Pradesh, with a current combined capacity of 20,000 MT/PA. CCL also has a plant in Vietnam with a total capacity of 1,0000 MT for instant coffee and 5,000 MT for liquid coffee. CCL s 3,000 MT plant in Switzerland is facing issues on account of unfavorable European Union regulations. Major clientele and geographies The major countries contributing to CCL s export revenue are Italy, Russia, Belgium, Japan Germany, China, etc. A few private labels served by CCL include Mokate, Instanta, Food Empire, Strauss, DEK, Gold Roast, etc. Presently, the company provides over 200 varieties and blends of coffee to its customers in over 90 countries. Indian retail business could also be another booster in near term The company launched its own brand Continental in Andhra Pradesh and Telangana in FY2014, which has received good response and encouraged it to recently launch it in other parts of India. In order to ramp up the brand faster, CCL has tied up with big retail chains, such as the Future Group, Metro, Reliance, etc. and is supplying to institutional investors like railways. Currently, Nestle and Hindustan Unilever s Bru forms over 70% the Indian instant coffee market. Strong balance sheet and healthy return ratios The company s robust business model keeps on generating free cash flow in excess of `80cr every year, which would largely fund its capex requirements. The company exports to over 90 countries, which has helped in registering revenue CAGR of 14% over FY2012-17. Despite its intensive capex ramp up, DE ratio has come down to 0.2x in FY2017 and return ratios have been at 20%+ level. January 04, 2018 2

Apr-07 Sep-07 Feb-08 Jul-08 Dec-08 May-09 Oct-09 Mar-10 Aug-10 Jan-11 Jun-11 Nov-11 Apr-12 Sep-12 Feb-13 Jul-13 Dec-13 May-14 Oct-14 Mar-15 Aug-15 Jan-16 Jun-16 Nov-16 Apr-17 Sep-17 CCL Products Initiating Coverage Outlook and Valuation CCL is likely to maintain the 17%+ growth trajectory over FY2018-20 backed by capacity expansion and new geographical foray. In H1FY2018, the company faced some margin pressure while acquiring new clients, which we have factored in our model. However, according to us, the margin pressures would ease from FY2019 onwards, once the relationship is established. Moreover, its branded business i.e. Continental is doing pretty well and could be `100cr business in the next 2-3 years (`50cr in FY17). The stock is currently trading at 21x FY19 EPS, which offers good opportunity to enter the stock. We initiate coverage on CCL with a Buy recommendation and Target Price of `360 (25x FY2019E EPS), indicating an upside of ~20% from the current levels. Exhibit 1: One Year Forward P/E 500.00 450.00 400.00 350.00 300.00 250.00 200.00 150.00 100.00 50.00 0.00 CCL Products 10.0 X 15.0 X 20.0 X 25.0 X 30.0 X Source: Company, Angel Research Risks to our estimates Volumes may get impacted owing to the inability to get break through with new clients Abrupt fluctuations in coffee prices may adversely impact profitability January 04, 2018 3

Profit & Loss Statement Y/E March (` cr) FY2016 FY2017 FY2018E FY2019E FY2020E Total operating income 932 976 1165 1398 1595 % chg 6 5 19 20 14 Total Expenditure 717 743 920 1084 1228 Raw Material 547 552 635 730 839 Personnel 23 28 31 34 37 Others Expenses 148 163 180 198 217 EBITDA 215 233 245 315 367 % chg 20 9 5 29 17 (% of Net Sales) 23 24 21 23 23 Depreciation& Amortisation 28 33 36 41 42 EBIT 186 200 209 274 325 % chg 22 7 4 31 19 (% of Net Sales) 20 20 18 20 20 Interest & other Charges 11 11 13 6 5 Other Income -8.79-0.11 2.00 5.00 5.00 (% of PBT) -5.3% -0.1% 1.0% 1.8% 1.5% Share in profit of Associates - - - - - Recurring PBT 167 189 198 273 325 Tax 45 55 59 82 98 (% of PBT) 26.8 28.9 30.0 30.0 30.0 PAT (reported) 122 134 139 191 228 % chg 30 10 3 38 19 (% of Net Sales) 13 14 12 14 14 Basic EPS (Rs) 9.2 10.1 10.4 14.4 17.1 Fully Diluted EPS (Rs) 9.2 10.1 10.4 14.4 17.1 % chg 30 10 3 38 19 January 04, 2018 4

Balance Sheet Y/E March (` cr) FY2016 FY2017 FY2018E FY2019E FY2020E SOURCES OF FUNDS Equity Share Capital 27 27 27 27 27 Reserves& Surplus 483 610 704 847 1021 Shareholders Funds 510 636 731 873 1048 Minority Interest Total Loans 210 142 182 172 142 Other Liabilities 1 0 0 0 0 Total Liabilities 721 778 913 1045 1190 APPLICATION OF FUNDS Gross Block 639 643 743 843 943 Less: Acc. Depreciation 221 250 286 327 368 Net Block 417 393 458 517 575 Capital Work-in-Progress 0 0 0 0 0 Investments 2 2 2 2 2 Current Assets 331 404 479 558 650 Inventories 149 183 201 231 266 Sundry Debtors 128 163 171 197 227 Cash and Bank 19 17 63 84 110 Loans and Advances 36 42 44 46 48 Current liabilities 52 39 45 51 59 Net Current Assets 279 365 434 507 592 Deferred Tax Asset -28-31 -32-34 -36 Other Assets 51 49 52 55 57 Mis. Exp. not written off - - - - - Total Assets 721 778 913 1045 1190 January 04, 2018 5

Cash Flow Statement Y/E March (` cr) FY2016 FY2017 FY2018E FY2019E FY2020E Profit before tax 167 189 198 273 325 Depreciation 28 33 36 41 42 Change in Working Capital 8-67 -3-19 -22 Interest / Dividend (Net) -4 4 0 0 0 Direct taxes paid -38-53 -59-82 -98 Others Cash Flow from Operations 161 158 231 294 345 (Inc.)/ Dec. in Fixed Assets -87-20 -100-100 -20 (Inc.)/ Dec. in Investments 0 0 0 0 0 Cash Flow from Investing -87-20 -100-100 -20 Issue of Equity 0 0 0 0 0 Inc./(Dec.) in loans -25-68 40-10 -30 Dividend Paid (Incl. Tax) -40-13 -13-13 -13 Interest / Dividend (Net) -6-4 -13-6 -5 Cash Flow from Financing -71-85 14-29 -48 Inc./(Dec.) in Cash 3 54 145 165 276 Opening Cash balances 27 19 2 88 171 Closing Cash balances 2 2 88 171 349 January 04, 2018 6

Key Ratios Y/E March FY2016 FY2017 FY2018E FY2019E FY2020E Valuation Ratio (x) P/E (on FDEPS) 32.7 29.7 28.8 20.9 17.5 P/CEPS 26.5 23.8 22.9 17.2 14.8 P/BV 7.8 7.8 6.3 5.5 4.6 Dividend yield (%) 1% 1% 1% 1% 1% EV/Sales 4.5 4.2 3.5 2.9 2.5 EV/EBITDA 19.5 17.6 16.7 12.9 10.9 EV / Total Assets 10.0 10.5 8.9 7.8 7.0 Per Share Data (`) EPS (Basic) 7.1 9.2 10.1 10.4 14.4 EPS (fully diluted) 7.1 9.2 10.1 10.4 14.4 Cash EPS 11.3 12.6 13.1 17.4 20.2 DPS 2.5 2.5 2.8 3.0 3.3 Book Value 38.3 47.8 55.0 65.7 78.8 Returns (%) ROCE 28.4 27.5 25.3 28.6 29.7 Angel ROIC (Pre-tax) 26.6 26.3 24.6 28.5 30.1 ROE 24.0 21.1 19.0 21.9 21.7 Turnover ratios (x) Asset Turnover (Gross Block) 2.2 2.5 2.5 2.7 2.8 Inventory / Sales (days) 63 62 60 56 57 Receivables (days) 47 54 52 48 48 Payables (days) 35 22 17 16 16 Working capital cycle (ex-cash) (days) 75 94 96 88 89 Source: Source: Note - Valuation done on closing price of 04/01/2018 January 04, 2018 7

Research Team Tel: 022-39357800 E-mail: research@angelbroking.com Website: www.angelbroking.com DISCLAIMER Angel Broking Private Limited (hereinafter referred to as Angel ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and Metropolitan Stock Exchange Limited. It is also registered as a Depository Participant with CDSL and Portfolio Manager with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel Broking Private Limited is a registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration number INH000000164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. Angel or its associates/analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate the contrary view, if any. The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Pvt. Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Pvt. Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Pvt. Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Neither Angel Broking Pvt. Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Disclosure of Interest Statement CCL Products 1. Financial interest of research analyst or Angel or his Associate or his relative No 2. Ownership of 1% or more of the stock by research analyst or Angel or associates or relatives No 3. Served as an officer, director or employee of the company covered under Research No 4. Broking relationship with company covered under Research No January 04, 2018 8